Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kay Elemetrics, now operating as KayPENTAX, is a prominent developer of specialized instrumentation for the speech-language pathology and otolaryngology sectors. The company is widely recognized for its advanced diagnostic systems used to assess and treat speech, voice, and swallowing disorders. Their flagship products, including the Computerized Speech Lab (CSL) and Visi-Pitch, serve as global standards for clinical assessment and academic research. Following its acquisition by Pentax Medical, the brand has continued to innovate by integrating acoustic, aerodynamic, and endoscopic imaging technologies. Their solutions are essential for clinicians managing patients with complex communication and airway disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kay Elemetrics.